Minocycline improves cognition and molecular measures of inflammation and neurodegeneration following repetitive mTBI.
Matthew I HiskensRebecca K VellaAnthony G SchneidersAndrew S FenningPublished in: Brain injury (2021)
These data suggest that minocycline treatment alleviated some mTBI pathophysiology and clinical features at chronic time-points.